The exact incidence of the regional difference of HER2 status in primary breast cancer with two different populations of cancer cells (one is HER2-negative and another is HER2-positive) was unknown, but it may be revealed by detecting more than one blocks. The gene discussed is ERBB2; the disease is breast carcinoma.